Cargando…
Clinical Utility of Fluid Biomarker in Depressive Disorder
Major depressive disorders are ranked as the single largest contributor to non-fatal health loss and biomarkers could largely improve our routine clinical activity by predicting disease course and guiding treatment. However there is still a dearth of valid biomarkers in the field of psychiatry. The...
Autor principal: | Serretti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606424/ https://www.ncbi.nlm.nih.gov/pubmed/36263634 http://dx.doi.org/10.9758/cpn.2022.20.4.585 |
Ejemplares similares
-
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
por: Fabbri, Chiara, et al.
Publicado: (2020) -
Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023) -
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020) -
Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment
por: Fabbri, Chiara, et al.
Publicado: (2020) -
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality
por: Olgiati, Paolo, et al.
Publicado: (2023)